Bio Green Med Solution (BGMS) Cash from Operations Growth (1y) (2011 - 2026)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 4.87% |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | -28.96% |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 42.76% |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 75.58% |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 151.70% |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 100.14% |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 56.79% |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 66.67% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 66.67% |
| Mar 31, 2026 | 91.44% |
| Dec 31, 2025 | 97.57% |
| Sep 30, 2025 | 85.85% |
| Jun 30, 2025 | 65.76% |
| Mar 31, 2025 | -572.26% |
| Dec 31, 2024 | 65.32% |
| Sep 30, 2024 | 24.01% |
| Jun 30, 2024 | -136.32% |
| Mar 31, 2024 | 92.96% |
| Dec 31, 2023 | 24.36% |
| Sep 30, 2023 | 42.08% |
| Jun 30, 2023 | 31.85% |
| Mar 31, 2023 | -1.27% |
| Dec 31, 2022 | -13.63% |
| Sep 30, 2022 | -12.21% |
| Jun 30, 2022 | 54.57% |
| Mar 31, 2022 | -89.99% |
| Dec 31, 2021 | -294.88% |
| Sep 30, 2021 | -191.69% |